基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 5,308.27
成立日期: 26/01/2004
 
分析
市值分佈:
94.15%
大市值
2.37%
中市值
0.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 18/07/2026 05:44) 總持有投資項目: 384  
0%
 
100%
     10大 (52.10%)
代號 名稱 佔比% 持有日期
SPRYARS Pharmaceuticals0.0130/06/2026
BVSBioventus0.0130/06/2026
VORVor Biopharma Inc0.0130/06/2026
DNAGinkgo Bioworks Holdings0.0130/06/2026
STLNStarling Oncology, Inc.0.0130/06/2026
STTKShattuck Labs0.0130/06/2026
KIDSOrthoPediatrics Corp0.00530/06/2026
SEPNSepterna Inc0.00530/06/2026
RZLTRezolute0.00530/06/2026
SLPSimulations Plus0.00530/06/2026
VNDAVanda Pharmaceuticals0.00530/06/2026
CATXPerspective Therapeutics0.00530/06/2026
EOLSEvolus0.00530/06/2026
MPLTMapLight Therapeutics Inc.0.00430/06/2026
RCKTRocket Pharmaceuticals0.00430/06/2026
TECXTectonic Therapeutic Inc.0.00430/06/2026
AKBAAkebia Therapeutics0.00430/06/2026
OFIXOrthofix Medical0.00430/06/2026
OSUROraSure Technologies0.00430/06/2026
LMRILumexa Imaging Holdings, Inc.0.00430/06/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16   17    18    19    20  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.